Overview

The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)

Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the effect of epoetin alfa to preoperative autologous blood donation (PAD) on postoperative vigor (a measure of functional ability and well-being) and handgrip strength in patients undergoing hip or knee surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Ortho Biotech, Inc.
Treatments:
Epoetin Alfa